Correlation Between Gain Therapeutics and Carmell Therapeutics
Can any of the company-specific risk be diversified away by investing in both Gain Therapeutics and Carmell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gain Therapeutics and Carmell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gain Therapeutics and Carmell Therapeutics, you can compare the effects of market volatilities on Gain Therapeutics and Carmell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gain Therapeutics with a short position of Carmell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gain Therapeutics and Carmell Therapeutics.
Diversification Opportunities for Gain Therapeutics and Carmell Therapeutics
-0.67 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Gain and Carmell is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Gain Therapeutics and Carmell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carmell Therapeutics and Gain Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gain Therapeutics are associated (or correlated) with Carmell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carmell Therapeutics has no effect on the direction of Gain Therapeutics i.e., Gain Therapeutics and Carmell Therapeutics go up and down completely randomly.
Pair Corralation between Gain Therapeutics and Carmell Therapeutics
Given the investment horizon of 90 days Gain Therapeutics is expected to generate 0.4 times more return on investment than Carmell Therapeutics. However, Gain Therapeutics is 2.48 times less risky than Carmell Therapeutics. It trades about -0.13 of its potential returns per unit of risk. Carmell Therapeutics is currently generating about -0.81 per unit of risk. If you would invest 218.00 in Gain Therapeutics on August 31, 2024 and sell it today you would lose (44.00) from holding Gain Therapeutics or give up 20.18% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 18.18% |
| Values | Daily Returns |
Gain Therapeutics vs. Carmell Therapeutics
Performance |
| Timeline |
| Gain Therapeutics |
| Carmell Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Insignificant
Gain Therapeutics and Carmell Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Gain Therapeutics and Carmell Therapeutics
The main advantage of trading using opposite Gain Therapeutics and Carmell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gain Therapeutics position performs unexpectedly, Carmell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carmell Therapeutics will offset losses from the drop in Carmell Therapeutics' long position.| Gain Therapeutics vs. In8bio Inc | Gain Therapeutics vs. Cue Biopharma | Gain Therapeutics vs. Tff Pharmaceuticals | Gain Therapeutics vs. Lantern Pharma |
| Carmell Therapeutics vs. ZyVersa Therapeutics | Carmell Therapeutics vs. Sonnet Biotherapeutics Holdings | Carmell Therapeutics vs. Revelation Biosciences | Carmell Therapeutics vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |